Clinical meaning
Evidence-based diagnostic criteria from major guideline organizations provide standardized frameworks that improve diagnostic accuracy, reduce variability, and ensure patients receive appropriate, timely treatment. The NP must master the application of multiple guideline-based diagnostic systems across specialties. The DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders) defines psychiatric diagnoses using specific symptom criteria, duration requirements, functional impairment thresholds, and exclusion criteria — moving away from the multiaxial system to a single-axis approach while maintaining dimensional assessments (GAD-7, PHQ-9, AUDIT). The ADA (American Diabetes Association) Standards of Care define diabetes diagnosis using four criteria: FPG ≥ 126 mg/dL, 2-hour OGTT ≥ 200 mg/dL, HbA1c ≥ 6.5%, or random glucose ≥ 200 mg/dL with classic symptoms. The ACC/AHA (American College of Cardiology/American Heart Association) guidelines define hypertension stages, cardiovascular risk assessment using the Pooled Cohort Equation, and heart failure classification (NYHA functional class and ACC/AHA stages A–D). The GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria diagnose COPD using post-bronchodilator FEV1/FVC < 0.70 and classify severity by FEV1 percentage predicted, symptoms (CAT, mMRC), and exacerbation history. The NP integrates these frameworks while recognizing their limitations, including cultural bias in psychiatric diagnosis, varying sensitivity/specificity of screening tests, and the need for clinical judgment in borderline cases.